Skip to navigation menu Skip to content
Informational Alert

Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

High Priority Alert

Masking and Visitation Changes: Due to high rates of respiratory illnesses in our community, we’ve made changes to our masking and visitation guidelines .

Illustration of a calendarIllustration of a document pageIllustration of a heart over a handIllustration of an envelopeIllustration of the letter i inside a circleIllustration of a map markerIllustration of a caduceusIllustration of a user with a plus signIllustration of a telephoneIllustration of a question mark inside a circleIllustration of a video cameraDocument with a PDF label
Current Research Studies

Cancer - SC-N145, Targeted Therapy to Increase RAI Uptake in Metastatic DTC

What is the goal of this study?

The goal of this study is to learn more about how targeted therapy affects the radioactive iodine (RAI) absorption by your cancer.

Who can join the study?

This study may be a good fit for children and young adults who:

• Have Differentiated Thyroid Cancer (DTC) that has spread to the lungs
• Are planning to be treated with a targeted therapy

What will happen if my child takes part in this study?

If you choose to participate in this study:

• You will have an additional whole body scan (WBS) done 28 days after receiving therapy targeted to treat your cancer. 
• This scan will be compared to the WBS you had done before starting targeted therapy.
• The study team will compare the levels of radioactive iodine (RAI) from both sets of images to see if there is a change.

Who can I contact for more information?

Annie Dubnicka: [email protected]


Study Location(s):

Seattle Children's Hospital

Principal Investigator:

Dr. Tyler Ketterl